Kush Parmar

10% owner, Skye Bioscience, Inc.; Director, Entrada Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.0M

Companies

Latest trade

Sep 16, 2026

Companies

Skye Bioscience, Inc.10% owner −$0.1M Entrada Therapeutics, Inc.Director −$1.9M

Trades

SKYE Sold 33,892 shares at $1.91 $0.1M Sep 16

TRDA Sold 92,444 shares at $7.00 $0.6M Aug 10

TRDA Sold 52,317 shares at $6.85 $0.4M Aug 7

TRDA Sold 10,494 shares at $7.00 $0.1M Aug 6

TRDA Sold 1,718 shares at $6.85 $0.0M Jul 31

TRDA Sold 114,756 shares at $6.93 $0.8M Jul 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.